Lumida
/OSG
⌘K
OSG

OSG

OSG
$4.84USD↓-3.01%-0.15 today

MARKET CAP

218.0M

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$5 – $5

52W RANGE

$4
$10

AI Summary

Stalk
StalkMedium

Despite a longer-term downtrend, the early Stage 1 base produced a clear Momentum Breakout in early May that underpins a bullish medium-term bias. However, price has extended sharply above the 9/21 EMAs into overbought territory, making immediate buying unfavorable. Patience is warranted until a pullback into the rising EMA zone or the prior resistance-turned-support region, where acceptance can be assessed before entry.

  • ↑Q1 2026 revenue rose 92% to $78.5M, with 42% organic gain.
  • ↑Adjusted EBITDA grew fourfold to $25.3M in Q1 2026.
  • ↓Q4 2025 net loss of $30M due to ArmadaCare acquisition expenses.
Full analysis →

The case for & against

Bull & Bear analysis

Bullish

Octave Specialty Group Inc. (OTC: OSG) operates as a specialty insurance platform, focused on delivering innovative solutions through its insurance distribution business alongside a solid underwriting team. As an emerging leader within the specialty program insurance sector, OSG is navigating a transformative period, investing significantly in technology and new market segments, specifically in the areas of renewable energy and carbon capture.

Bull says

  • ↑Q1 2026 revenue rose 92% to $78.5M, with 42% organic gain.
  • ↑Adjusted EBITDA grew fourfold to $25.3M in Q1 2026.
  • ↑ArmadaCare integration ahead of schedule, yielding >40% EBITDA margins.
  • ↑AI-driven underwriting tools (Hammurabi) boost efficiency and competitiveness.
  • ↑2026 guidance calls for ≥20% organic revenue growth and ~$40M adjusted EBITDA.
  • ↑High book-to-price (~2.6x) and strong growth/revisions signals suggest undervaluation.

Bear says

  • ↓Q4 2025 net loss of $30M due to ArmadaCare acquisition expenses.
  • ↓Debt/EBITDA ratio at 3.2x may heighten leverage risk if cash flows dip.
  • ↓ArmadaCare integration challenges could impede execution and growth targets.
  • ↓Softening property lines risk revenue volatility and margin compression.
  • ↓2026 cash flow hinges on non-controlling interest buy-ins and extra borrowing.
  • ↓High short interest and low profitability indicators highlight market skepticism.

Earnings Call · Q2 2023 · Mgmt. Guidance

Updated 05-01-2026neutral

Transcript signals

Bull points

  • time charter equivalent earnings for the full year of approximately $410 million. Attaining this top line result should generate adjusted EBITDA of about $160 million for the full calendar year of 2023.
  • Given what we know today, we expect time charter equivalent earnings for 2024 to exceed $430 million and an adjusted EBITDA to exceed $175 million for the full calendar year 2024.
  • time charter equivalent earnings for the full year of approximately $410 million. Attaining this top line result should generate adjusted EBITDA of about $160 million for the full calendar year of 2023.

Bear points

  • Second quarter TCE revenues were $100.1 million, a $4.6 million decline from the first quarter of this year. 77 off-hire days due to dry dock schedules was a primary contributor to the change.
  • Adjusted EBITDA was $39.5 million for the quarter, bringing our first half adjusted EBITDA to $80.4 million. The modest $1.4 million decline from the first quarter reflects off-hire days for survey requirements and the lightening volume reductions.
  • Adjusted EBITDA was $39.5 million for the quarter, bringing our first half adjusted EBITDA to $80.4 million. The modest $1.4 million decline from the first quarter, again, reflects off-hire days for survey requirements and the lightening volume reductions.
Read full transcript analysis ›